ID

29903

Beschreibung

Study to Evaluate Symptoms in Patients Treated With Nebivolol or Metoprolol Extended-Release (ER) for Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT00547300

Link

https://clinicaltrials.gov/show/NCT00547300

Stichworte

Versionen (1)
  1. 26.04.18 26.04.18 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

26. April 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Hypertension NCT00547300

Englisch

Eligibility Hypertension NCT00547300

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female, ambulatory outpatients 18-80 yo. females must be post-menopausal, or not pregnant and using an approved contraceptive regimen
Beschreibung

Outpatients | Age | Postmenopausal state | Gender Pregnancy Absent | Gender Contraceptive methods

Datentyp

boolean

Alias
UMLS CUI [1]
C0029921
UMLS CUI [2]
C0001779
UMLS CUI [3]
C0232970
UMLS CUI [4,1]
C0079399
UMLS CUI [4,2]
C0032961
UMLS CUI [4,3]
C0332197
UMLS CUI [5,1]
C0079399
UMLS CUI [5,2]
C0700589
history of hypertension being treated with two medications, one of which must be hctz and the other of which must not be a beta-blocker or clonidine
Beschreibung

Pharmaceutical Preparations Quantity Hypertensive disease | Hydrochlorothiazide | Adrenergic beta-1 Receptor Antagonists Absent | Clonidine Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0020538
UMLS CUI [2]
C0020261
UMLS CUI [3,1]
C0304516
UMLS CUI [3,2]
C0332197
UMLS CUI [4,1]
C0009014
UMLS CUI [4,2]
C0332197
sbp of 135-155 mm hg and/or dbp of >85 mm hg at screening
Beschreibung

Systolic Pressure | Diastolic blood pressure

Datentyp

boolean

Alias
UMLS CUI [1]
C0871470
UMLS CUI [2]
C0428883
vision and hearing (hearing aid permissable) sufficient for compliance with testing procedures (i.e., with phone- and/or internet-based assessments)
Beschreibung

Vision Sufficient | Hearing Sufficient | Compliance behavior Testing

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0042789
UMLS CUI [1,2]
C0205410
UMLS CUI [2,1]
C0018767
UMLS CUI [2,2]
C0205410
UMLS CUI [3,1]
C1321605
UMLS CUI [3,2]
C0039593
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
treatment with a beta-blocker or clonidine within 6 months of screening
Beschreibung

Adrenergic beta-1 Receptor Antagonists | Clonidine

Datentyp

boolean

Alias
UMLS CUI [1]
C0304516
UMLS CUI [2]
C0009014
clinically significant respiratory disease (e.g., bronchial asthma, reactive airways disease, chronic obstructive pulmonary disease)
Beschreibung

Respiration Disorders | Asthma | Reactive airway disease | Chronic Obstructive Airway Disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0035204
UMLS CUI [2]
C0004096
UMLS CUI [3]
C3714497
UMLS CUI [4]
C0024117
coronary artery disease requiring treatment with a calcium channel blocker or nitrates
Beschreibung

Coronary Artery Disease | Patient need for Calcium Channel Blockers | Patient need for Nitrates

Datentyp

boolean

Alias
UMLS CUI [1]
C1956346
UMLS CUI [2,1]
C0686904
UMLS CUI [2,2]
C0006684
UMLS CUI [3,1]
C0686904
UMLS CUI [3,2]
C0028125
cardiovascular disease (e.g., myocardial infarction, cerebrovascular event, significant arrhythmia) within 6 months of screening
Beschreibung

Cardiovascular Diseases | Myocardial Infarction | Event Cerebrovascular | Cardiac Arrhythmia

Datentyp

boolean

Alias
UMLS CUI [1]
C0007222
UMLS CUI [2]
C0027051
UMLS CUI [3,1]
C0441471
UMLS CUI [3,2]
C1880018
UMLS CUI [4]
C0003811
history of severe mental illness (including major depressive disorder, psychosis, dementia, bipolar disorder) within 6 months of screening
Beschreibung

Mental Disorders, Severe | Major Depressive Disorder | Psychotic Disorders | Dementia | Bipolar Disorder

Datentyp

boolean

Alias
UMLS CUI [1]
C4046029
UMLS CUI [2]
C1269683
UMLS CUI [3]
C0033975
UMLS CUI [4]
C0497327
UMLS CUI [5]
C0005586
use of antipsychotic medicaiton (e.g., dopanine receptor antagonists, serotonin dopamine receptor antagonists) or antidepressants
Beschreibung

Antipsychotic Agents | Dopamine Antagonists | Other Coding | Antidepressive Agents

Datentyp

boolean

Alias
UMLS CUI [1]
C0040615
UMLS CUI [2]
C0242702
UMLS CUI [3]
C3846158
UMLS CUI [4]
C0003289
diabetes mellitus, type i or ii
Beschreibung

Diabetes Mellitus, Insulin-Dependent | Diabetes Mellitus, Non-Insulin-Dependent

Datentyp

boolean

Alias
UMLS CUI [1]
C0011854
UMLS CUI [2]
C0011860
participation in a previous investigational study of nebivolol at any time
Beschreibung

Study Subject Participation Status | Nebivolol

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0068475
receipt of treatment with an investigational study drug within 30 days of screening
Beschreibung

Investigational New Drugs

Datentyp

boolean

Alias
UMLS CUI [1]
C0013230
history of hypersensitivity to nebivolol, metoprolol er, other beta-blockers, hctz, or other sulfonamide-derived drugs
Beschreibung

Hypersensitivity Nebivolol | Metoprolol allergy | BETA BLOCKER ALLERGY | Hydrochlorothiazide allergy | Allergy to sulfonamides

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0068475
UMLS CUI [2]
C0570889
UMLS CUI [3]
C0741466
UMLS CUI [4]
C0571898
UMLS CUI [5]
C0038757
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Hypertension NCT00547300

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Outpatients | Age | Postmenopausal state | Gender Pregnancy Absent | Gender Contraceptive methods
Item
male or female, ambulatory outpatients 18-80 yo. females must be post-menopausal, or not pregnant and using an approved contraceptive regimen
boolean
C0029921 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0232970 (UMLS CUI [3])
C0079399 (UMLS CUI [4,1])
C0032961 (UMLS CUI [4,2])
C0332197 (UMLS CUI [4,3])
C0079399 (UMLS CUI [5,1])
C0700589 (UMLS CUI [5,2])
Pharmaceutical Preparations Quantity Hypertensive disease | Hydrochlorothiazide | Adrenergic beta-1 Receptor Antagonists Absent | Clonidine Absent
Item
history of hypertension being treated with two medications, one of which must be hctz and the other of which must not be a beta-blocker or clonidine
boolean
C0013227 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0020538 (UMLS CUI [1,3])
C0020261 (UMLS CUI [2])
C0304516 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0009014 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
Systolic Pressure | Diastolic blood pressure
Item
sbp of 135-155 mm hg and/or dbp of >85 mm hg at screening
boolean
C0871470 (UMLS CUI [1])
C0428883 (UMLS CUI [2])
Vision Sufficient | Hearing Sufficient | Compliance behavior Testing
Item
vision and hearing (hearing aid permissable) sufficient for compliance with testing procedures (i.e., with phone- and/or internet-based assessments)
boolean
C0042789 (UMLS CUI [1,1])
C0205410 (UMLS CUI [1,2])
C0018767 (UMLS CUI [2,1])
C0205410 (UMLS CUI [2,2])
C1321605 (UMLS CUI [3,1])
C0039593 (UMLS CUI [3,2])
Item Group
C0680251 (UMLS CUI)
Adrenergic beta-1 Receptor Antagonists | Clonidine
Item
treatment with a beta-blocker or clonidine within 6 months of screening
boolean
C0304516 (UMLS CUI [1])
C0009014 (UMLS CUI [2])
Respiration Disorders | Asthma | Reactive airway disease | Chronic Obstructive Airway Disease
Item
clinically significant respiratory disease (e.g., bronchial asthma, reactive airways disease, chronic obstructive pulmonary disease)
boolean
C0035204 (UMLS CUI [1])
C0004096 (UMLS CUI [2])
C3714497 (UMLS CUI [3])
C0024117 (UMLS CUI [4])
Coronary Artery Disease | Patient need for Calcium Channel Blockers | Patient need for Nitrates
Item
coronary artery disease requiring treatment with a calcium channel blocker or nitrates
boolean
C1956346 (UMLS CUI [1])
C0686904 (UMLS CUI [2,1])
C0006684 (UMLS CUI [2,2])
C0686904 (UMLS CUI [3,1])
C0028125 (UMLS CUI [3,2])
Cardiovascular Diseases | Myocardial Infarction | Event Cerebrovascular | Cardiac Arrhythmia
Item
cardiovascular disease (e.g., myocardial infarction, cerebrovascular event, significant arrhythmia) within 6 months of screening
boolean
C0007222 (UMLS CUI [1])
C0027051 (UMLS CUI [2])
C0441471 (UMLS CUI [3,1])
C1880018 (UMLS CUI [3,2])
C0003811 (UMLS CUI [4])
Mental Disorders, Severe | Major Depressive Disorder | Psychotic Disorders | Dementia | Bipolar Disorder
Item
history of severe mental illness (including major depressive disorder, psychosis, dementia, bipolar disorder) within 6 months of screening
boolean
C4046029 (UMLS CUI [1])
C1269683 (UMLS CUI [2])
C0033975 (UMLS CUI [3])
C0497327 (UMLS CUI [4])
C0005586 (UMLS CUI [5])
Antipsychotic Agents | Dopamine Antagonists | Other Coding | Antidepressive Agents
Item
use of antipsychotic medicaiton (e.g., dopanine receptor antagonists, serotonin dopamine receptor antagonists) or antidepressants
boolean
C0040615 (UMLS CUI [1])
C0242702 (UMLS CUI [2])
C3846158 (UMLS CUI [3])
C0003289 (UMLS CUI [4])
Diabetes Mellitus, Insulin-Dependent | Diabetes Mellitus, Non-Insulin-Dependent
Item
diabetes mellitus, type i or ii
boolean
C0011854 (UMLS CUI [1])
C0011860 (UMLS CUI [2])
Study Subject Participation Status | Nebivolol
Item
participation in a previous investigational study of nebivolol at any time
boolean
C2348568 (UMLS CUI [1])
C0068475 (UMLS CUI [2])
Investigational New Drugs
Item
receipt of treatment with an investigational study drug within 30 days of screening
boolean
C0013230 (UMLS CUI [1])
Hypersensitivity Nebivolol | Metoprolol allergy | BETA BLOCKER ALLERGY | Hydrochlorothiazide allergy | Allergy to sulfonamides
Item
history of hypersensitivity to nebivolol, metoprolol er, other beta-blockers, hctz, or other sulfonamide-derived drugs
boolean
C0020517 (UMLS CUI [1,1])
C0068475 (UMLS CUI [1,2])
C0570889 (UMLS CUI [2])
C0741466 (UMLS CUI [3])
C0571898 (UMLS CUI [4])
C0038757 (UMLS CUI [5])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video